Reported Reactions

Devices › Device types

FDA product code MSF · class 2 · Gastroenterology, Urology

Hemodialyzer, re-use, high flux: medical device reports filed with FDA

1,219 reports carry this product code, 1999–2023; 4 brands with a page.

1,219
reports with this product code
0% of all MAUDE reports
0
reports, 12 months to August 2026
0 in the 12 months before
95.5%
classified as malfunction
62.3% across all reports
0.2%
classified as death, as reported
0.9% across all reports

Product code MSF is FDA's classification for "Hemodialyzer, re-use, high flux" (gastroenterology, Urology panel), a class 2 device. 1,219 medical device reports carry this product code, 0% of the MAUDE database, from November 1999 to August 2023.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.5%), other (2.4%) and injury (1.9%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Polyflux Lr Capillary Dialyzer96300%99.7%
Polyflux R Capillary Dialyzer11100%52.5%
Ca-Hp Dialyzer Ca-Hp 210101.1%85.9%
Polyflux L Capillary Dialyzer101.3%60.6%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Gambro Dialysatoren77763.7%

Reports by month, five years

011Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 1Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.2%3
Injury1.9%23
Malfunction95.5%1,164
Other2.4%29
Not given0%0

Who filed

Manufacturer report97.3%1,186
Voluntary report0.1%1
User facility report0%0
Distributor report2.5%31
Not given0.1%1

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Fluid/blood leak1,05986.9%
Material rupture877.1%
Membrane tear(s)534.3%
Component(s), broken221.8%
Leak/splashthe device leaked211.7%
Rupture, cause unknown80.7%
Tears, rips, holes in device, device material60.5%
Alarm, audible50.4%
Breakthe device broke50.4%
Output, low30.2%
Blood in tubing20.2%
Device displays incorrect message20.2%
Improper or incorrect procedure or method20.2%
Patient-device incompatibilitythe device did not suit the patient20.2%
Reactiona reaction, type not specified20.2%
Device contamination with body fluid10.1%
Device difficult to setup or prepare10.1%
Device operates differently than expectedthe device behaved unexpectedly10.1%
Difficult or delayed activation10.1%
Insufficient device problem information10.1%

Questions about hemodialyzer, re-use, high flux reports

What is product code MSF?

FDA's classification code for "Hemodialyzer, re-use, high flux", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,219 reports through August 2026, 0 of them in the latest 12 months.

Which brands appear most often?

Polyflux Lr Capillary Dialyzer (963), Polyflux R Capillary Dialyzer (111), Ca-Hp Dialyzer Ca-Hp 210 (1) and Polyflux L Capillary Dialyzer (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.